SCHEMBL10530641

SCHEMBL10530641

CCCC(C)CCC(C)[C]=O

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
ACE2 Q9BYF1 1/20 0.33
FDPS P14324 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL271616 0.84
SCHEMBL20610005 0.78 TSHR (0.59) TSHRACE2FDPS
SCHEMBL28841264 0.76 TSHR (0.46) TSHRACE2FDPS
SCHEMBL9630991 0.75 ACE2 (0.47) ACE2FDPS
SCHEMBL56451 0.74
SCHEMBL9368619 0.74
SCHEMBL270381 0.74
SCHEMBL6141164 0.73
SCHEMBL277789 0.72
SCHEMBL1410786 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4804742-A OSTEOPOROSIS TREATMENT OF EXTENDED DURATION RORER PHARMACEUTICAL CORPORATION (US) 1989-02-14 US disclosed
US-4650854-A OSTEOPOROSIS USV PHARMACEUTICAL CORPORATION (US) 1987-03-17 US disclosed